No, it is not high, for what it is financing. We are not financing residential real estate pegged at the current 10 year treasury with 745+ FICO score, and 20% down.....
The interest rate IS NOT HIGH in a post COVID lending Enviornment. This is essentially an unsecured loan that can be converted to shares upon success of the company’s business plan with out pledging intellectual property. Remember pre revenue bio tech. This looks like a good deal for all parties and is a precursor of good news tomorrow.